Katabi Maha

CIK 00017206857 companiesMENLO PARK, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001720685

Recent Transactions

50 trades

Award
Vera Therapeutics, Inc.$VERA
Stock Option (right to buy)
2025-05-14+14,000→ 14,000 total
Award
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2024-06-05+12,500→ 12,500 total
Award
Vera Therapeutics, Inc.$VERA
Stock Option (right to buy)
2024-05-15+14,000→ 14,000 total
Sale
Vera Therapeutics, Inc.$VERA
Class A Common Stock
2024-03-25$40.50/sh−340,000→ 2,793,987 total
Sale
Vera Therapeutics, Inc.$VERA
Class A Common Stock
2024-03-22$40.51/sh−413,450→ 3,133,987 total
Sale
Vera Therapeutics, Inc.$VERA
Class A Common Stock
2024-03-21$46.18/sh−13,718→ 3,547,437 total
Sale
Vera Therapeutics, Inc.$VERA
Class A Common Stock
2024-03-21$45.52/sh−12,617→ 3,561,155 total
Sale
Vera Therapeutics, Inc.$VERA
Class A Common Stock
2024-03-21$43.00/sh−32,756→ 3,595,690 total
Sale
Vera Therapeutics, Inc.$VERA
Class A Common Stock
2024-03-21$44.00/sh−21,918→ 3,573,772 total
Disposition to Issuer
RayzeBio, Inc.
Stock Option (right to buy)
2024-02-26−18,235→ 0 total
Disposition to Issuer
RayzeBio, Inc.
Common Stock
2024-02-26$62.50/sh−1,209,764→ 0 total
Disposition to Issuer
RayzeBio, Inc.
Common Stock
2024-02-26$62.50/sh−1,209,764→ 0 total
Purchase
Vera Therapeutics, Inc.$VERA
Class A Common Stock
2024-01-30$31.00/sh+161,290→ 3,628,446 total
Award
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2024-01-02$13.49/sh+3,519→ 3,519 total
Award
RayzeBio, Inc.
Stock Option (right to buy)
2023-11-17+18,235→ 18,235 total
Conversion
RayzeBio, Inc.
Series D Convertible Preferred Stock
2023-09-19−973,653→ 0 total
Purchase
RayzeBio, Inc.
Common Stock
2023-09-19$18.00/sh+236,111→ 1,209,764 total
Conversion
RayzeBio, Inc.
Common Stock
2023-09-19+973,653→ 973,653 total
Purchase
RayzeBio, Inc.
Common Stock
2023-09-19$18.00/sh+236,111→ 1,209,764 total
Conversion
RayzeBio, Inc.
Series D Convertible Preferred Stock
2023-09-19−973,653→ 0 total
Conversion
RayzeBio, Inc.
Common Stock
2023-09-19+973,653→ 973,653 total
Award
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2023-06-06+12,500→ 12,500 total
Award
Vera Therapeutics, Inc.$VERA
Stock Option (right to buy)
2023-05-10+20,000→ 20,000 total
Disposition to Issuer
CinCor Pharma, Inc.
Common Stock
2023-02-24−19,608→ 0 total
Disposition from Tender
CinCor Pharma, Inc.
Common Stock
2023-02-24−6,073,949→ 0 total
Disposition from Tender
CinCor Pharma, Inc.
Common Stock
2023-02-24−9,803→ 19,608 total
Purchase
Vera Therapeutics, Inc.$VERA
Class A Common Stock
2023-02-06$7.00/sh+285,714→ 3,467,156 total
Award
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2023-01-03$18.08/sh+2,627→ 2,627 total
Sale
CinCor Pharma, Inc.
Common Stock
2022-11-28$14.32/sh−6,000→ 0 total
Purchase
CinCor Pharma, Inc.
Common Stock
2022-08-11$30.00/sh+500,000→ 6,073,949 total
Award
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2022-06-21+12,500→ 12,500 total
Award
Vera Therapeutics, Inc.$VERA
Stock Option (right to buy)
2022-05-24+9,925→ 9,925 total
Purchase
Vera Therapeutics, Inc.$VERA
Class A Common Stock
2022-02-10$15.00/sh+266,666→ 3,181,442 total
Conversion
CinCor Pharma, Inc.
Common Stock
2022-01-11+5,248,949→ 5,248,949 total
Purchase
CinCor Pharma, Inc.
Common Stock
2022-01-11$16.00/sh+325,000→ 5,573,949 total
Conversion
CinCor Pharma, Inc.
Series A Preferred Stock
2022-01-11−13,571,428→ 0 total
Conversion
CinCor Pharma, Inc.
Series B Preferred Stock
2022-01-11−4,275,000→ 0 total
Award
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2022-01-03$6.56/sh+7,240→ 7,240 total
Conversion
Jade Biosciences, Inc.$JBIO
Common Stock
2021-07-02+3,401,544→ 3,401,544 total
Conversion
Jade Biosciences, Inc.$JBIO
Series A Preferred Stock
2021-07-02−10,565,238→ 0 total
Purchase
Jade Biosciences, Inc.$JBIO
Common Stock
2021-07-02$14.00/sh+357,142→ 3,758,686 total
Award
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2021-07-01$11.15/sh+2,467→ 2,467 total
Award
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2021-06-29+25,000→ 25,000 total
Award
Jade Biosciences, Inc.$JBIO
Series A Preferred Stock
2021-06-04$1.89/sh+8,082,190→ 10,565,238 total
Purchase
Vera Therapeutics, Inc.$VERA
Class A Common Stock
2021-05-18$11.00/sh+727,272→ 2,914,776 total
Conversion
Vera Therapeutics, Inc.$VERA
Series C Preferred Stock
2021-05-18−2,187,504→ 0 total
Conversion
Vera Therapeutics, Inc.$VERA
Class A Common Stock
2021-05-18+2,187,504→ 2,187,504 total
Award
Vera Therapeutics, Inc.$VERA
Stock Option (right to buy)
2021-05-13+9,925→ 9,925 total
Conversion
Bolt Biotherapeutics, Inc.$BOLT
Series C-2 Preferred Stock
2021-02-09−1,200,228→ 0 total
Purchase
Bolt Biotherapeutics, Inc.$BOLT
Common Stock
2021-02-09$20.00/sh+450,000→ 2,754,437 total

Companies

Recent Filings

Address

C/O SOFINNOVA INVESTMENTS, INC. 3000 SAND HILL ROAD, BLDG. 4, SUITE 250

MENLO PARK, CA, 94025

View on SEC.gov